Juliana M Bue-Valleskey

5PUBLICATIONS
10CO-AUTHORS
Life cycle assessment and industrial ecologyBiofabricationTissue engineeringExercise physiologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 29, 2024
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.

Richard M Bergenstal, Athena Philis-Tsimikas, Carol Wysham

|Mar 21, 2023
Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control Trial.

Juliana M Bue-Valleskey, Christof M Kazda, Chenchen Ma

|Mar 15, 2023
Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes.

Christof M Kazda, Juliana M Bue-Valleskey, Jenny Chien

|Jun 04, 2020
Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study.

Leslie Klaff, Dachuang Cao, Mary Anne Dellva

|May 22, 2020
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.

Tim Heise, Helle Linnebjerg, David Coutant

Pageof 1

Frequent Collaborators

1 joint publications

Tim Heise

1 joint publications

Helle Linnebjerg

1 joint publications

Eric Zijlstra

1 joint publications

Christoph Kapitza